Lidocaine Hydrochloride Bp B. Braun Melsungen

Lidocaine, the active ingredient in Lidocaine Hydrochloride Bp B. Braun Melsungen, is a local anesthetic presented as a sterile solution for epidural, intradermal, and intramuscular use. It provides reversible nerve block for minor surgical procedures, epidural analgesia, and skin anesthesia. GNH USA supplies Lidocaine Hydrochloride Bp B. Braun Melsungen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine is a local anesthetic used across several procedural pathways to achieve temporary loss of sensation. - Minor surgical procedures: provides localized numbness to facilitate painless incision and manipulation. - Epidural analgesia: delivers segmental pain relief during labor or postoperative recovery. - Intradermal anesthesia: numbs skin for diagnostic testing or minor dermatologic interventions. - Dental procedures: anesthetizes oral tissues for extractions, restorations and other dental work.

Lidocaine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Tingling or numbness at the injection site - Mild dizziness or light‑headedness - Nausea or metallic taste - Transient swelling or erythema at the site

Serious or Rare Side Effects: - Cardiac arrhythmias, including ventricular tachycardia - Seizures or convulsions - Severe allergic reaction (anaphylaxis) with rash, bronchospasm, or hypotension - Methemoglobinemia leading to cyanosis and hypoxia

Before using Lidocaine, several safety considerations should be observed. - Assess patient allergy: verify no known hypersensitivity to amide‑type local anesthetics. - Monitor cardiac status: observe for arrhythmias, especially with high cumulative doses. - Use caution in hepatic impairment: reduced metabolism may increase systemic exposure. - Avoid in patients with severe conduction disorders unless benefits outweigh risks. - Store at below 25°C: keep in the original container, protect from moisture and light.

Lidocaine can interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): increase risk of lidocaine toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): raise plasma concentrations. - CYP1A2 inducers (e.g., carbamazepine, phenobarbital): may reduce therapeutic effect.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may potentiate cardiac depressant effects. - Concurrent use of other local anesthetics: cumulative toxicity risk. - Loop diuretics (e.g., furosemide): may alter protein binding and increase free drug levels.